✦ LIBER ✦

The rationale for and background of radioimmunotherapy: an emerging therapy for B-cell non-hodgkin’s lymphoma

✍ Scribed by Mary Beth Riley; Katherine Byar

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Zevalin radioimmunotherapy offers safe a

✍ M. Saleh; C.A. White; T.E. Witzig; L. Gordon; G.A. Wiseman; C. Emmanouilides; J. 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 360 KB

Monoclonal antibody therapy for B cell n

✍ C Buske; M Feuring-Buske; M Unterhalt; W Hiddemann 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 140 KB

Radioimmunotherapy with 131I-rituximab f

✍ Hye J KANG; Seung S LEE; Kyeong M KIM; Tae H CHOI; Gi J CHEON; Won S KIM; Cheolw 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 567 KB

Mucocutaneous autoimmune syndrome follow

✍ J. Braess; K. Reich; S. Willert; F. Strutz; C. Neumann; W. Hiddemann; B. Wörmann 📂 Article 📅 1997 🏛 Springer 🌐 English ⚖ 710 KB

Radiation therapy for the treatment of n

✍ Steven Carabell; Norman Jaffe; Howard Weinstein; Zebulon B. Vance; Robert Filler 📂 Article 📅 1977 🏛 Elsevier Science 🌐 English ⚖ 165 KB

Effect of rituximab on the long-term out

✍ Georg Hess; Thomas Flohr; Karin Kolbe; Sarah Bonn; Martin Schuler; Hans Günter D 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 359 KB